Alar Pharmaceuticals Inc. (TPEX:6785)
Taiwan · Delayed Price · Currency is TWD 93.00
-1.00 (-1.06%)
Sep 8, 2026, 1:30 PM CST
Alar Pharmaceuticals Market Cap
Alar Pharmaceuticals has a market cap or net worth of 6.28 billion as of September 8, 2026. Its market cap has decreased by -58.22% in one year.
Market Cap
6.28B
Enterprise Value
4.00B
Revenue
3.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
93.00
ChartMarket Cap Chart
Since October 5, 2020, Alar Pharmaceuticals's market cap has increased from 2.57B to 6.28B, an increase of 144.80%. That is a compound annual growth rate of 16.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 6.28B | -69.08% |
| Dec 31, 2025 | 20.31B | 114.84% |
| Dec 31, 2024 | 9.45B | -20.85% |
| Dec 29, 2023 | 11.94B | 82.17% |
| Dec 30, 2022 | 6.56B | 151.37% |
| Dec 30, 2021 | 2.61B | -6.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 5, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Grape King Bio | 13.41B |
| Foresee Pharmaceuticals | 12.60B |
| Standard Chemical & Pharmaceutical | 10.01B |
| SCI Pharmtech | 6.70B |
| Orient Pharma | 6.12B |
| Formosa Laboratories | 5.45B |
| Panion & Bf Biotech | 4.83B |
| Yoda Pharmaceuticals | 4.57B |